AbCellera Biologics, Inc. (ABCL)
3.67
+0.08
(+2.23%)
USD |
NASDAQ |
Dec 09, 16:00
3.70
+0.03
(+0.82%)
After-Hours: 18:09
AbCellera Biologics Price to Book Value: 1.140 for Dec. 9, 2025
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Achieve Life Sciences, Inc. | 7.403 |
| Oncolytics Biotech, Inc. | 1254.81 |
| Aurinia Pharmaceuticals, Inc. | 5.589 |
| Edesa Biotech, Inc. | 2.535 |
| Lexaria Bioscience Corp. | 8.438 |
Price to Book Value Related Metrics
| PS Ratio | 30.93 |
| Price | 3.67 |
| Earnings Yield | -15.70% |
| Market Cap | 1.099B |